JENNY SANDBERG: Open Payments
NPI 1104367622 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 30 payments from 13 companies in 2025. Trend: 2023 $452 · 2024 $1,422 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $177 |
| ABBVIE INC. | 4 | $77 |
| PFIZER INC. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
Products named: Ozempic, Wegovy, NURTEC ODT, GARDASIL 9, UBRELVY, TRELEGY ELLIPTA, FARXIGA, INSPIRE.
Industry payments across MD — which companies pay providers there.
